Michael Polark
Stock Analyst at Wolfe Research
(3.85)
# 1,911
Out of 4,504 analysts
177
Total ratings
50.6%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $134.29 | +0.53% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $60.06 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $199.05 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,296.17 | -8.96% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $112.29 | - | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $144.24 | +0.53% | 1 | Jun 1, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Buy | $535 | $527.05 | +1.51% | 1 | Jun 1, 2026 | |
| WAT Waters | Maintained: Buy | $425 | $376.43 | +12.90% | 1 | Jun 1, 2026 | |
| WST West Pharmaceutical Services | Rated: Buy | $375 | $353.71 | +6.02% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $10.39 | -32.63% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $19.59 | +7.20% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.99 | - | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.77 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.71 | - | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $93.93 | - | 5 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $92.21 | -0.23% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.76 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $41.04 | +14.52% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $83.87 | - | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $17.11 | -24.02% | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $270 | $216.00 | +25.00% | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $18.42 | -7.71% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $17.03 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $82.56 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $161.28 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $25.99 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $203.87 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $329.78 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $91.34 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $116.13 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.24 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $140 | $74.96 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $135.73 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $15.41 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $406.78 | n/a | 9 | Apr 5, 2022 |
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $134.29
Upside: +0.53%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $60.06
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $199.05
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,296.17
Upside: -8.96%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $112.29
Upside: -
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $144.24
Upside: +0.53%
Thermo Fisher Scientific
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $527.05
Upside: +1.51%
Waters
Jun 1, 2026
Maintained: Buy
Price Target: $425
Current: $376.43
Upside: +12.90%
West Pharmaceutical Services
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $353.71
Upside: +6.02%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $10.39
Upside: -32.63%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $19.59
Upside: +7.20%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $16.99
Upside: -
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.77
Upside: -
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.71
Upside: -
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $93.93
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $92.21
Upside: -0.23%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $51.76
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $41.04
Upside: +14.52%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $83.87
Upside: -
Aug 14, 2025
Maintained: Buy
Price Target: $14 → $13
Current: $17.11
Upside: -24.02%
Aug 8, 2025
Maintained: Buy
Price Target: $245 → $270
Current: $216.00
Upside: +25.00%
Aug 8, 2025
Maintained: Buy
Price Target: $19 → $17
Current: $18.42
Upside: -7.71%
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $17.03
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $82.56
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $161.28
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $25.99
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $203.87
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $329.78
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $91.34
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $116.13
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.24
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: $121 → $140
Current: $74.96
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $135.73
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $15.41
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $406.78
Upside: n/a